July 2019
Volume 60, Issue 9
Free
ARVO Annual Meeting Abstract  |   July 2019
Characterization of Retinal Vascular Development in fzd4-/- Zebrafish with Familial Exudative Vitreoretinopathy (FEVR)
Author Affiliations & Notes
  • Harald Gjerde
    Ophthalmology & Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada
  • Lucia Cáceres
    Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada
  • Michael Ngo
    Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada
  • Elizabeth Cairns
    Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada
  • Sergey Prykhozhij
    Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada
  • Sarah van der Ende
    Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada
  • Christopher McMaster
    Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada
  • Jason Berman
    Pediatrics, Dalhousie University, Halifax, Nova Scotia, Canada
  • Johane M Robitaille
    Ophthalmology & Visual Sciences, Dalhousie University, Halifax, Nova Scotia, Canada
  • Footnotes
    Commercial Relationships   Harald Gjerde, None; Lucia Cáceres, None; Michael Ngo, None; Elizabeth Cairns, None; Sergey Prykhozhij, None; Sarah van der Ende, None; Christopher McMaster, Christopher McMaster (P); Jason Berman, Agada Biosciences/Therapeutics (F); Johane Robitaille, Johane Robitaille (P)
  • Footnotes
    Support  Atlantic Innovation Fund (AIF), Canadian Institutes of Health Research (CIHR)
Investigative Ophthalmology & Visual Science July 2019, Vol.60, 6058. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Harald Gjerde, Lucia Cáceres, Michael Ngo, Elizabeth Cairns, Sergey Prykhozhij, Sarah van der Ende, Christopher McMaster, Jason Berman, Johane M Robitaille; Characterization of Retinal Vascular Development in fzd4-/- Zebrafish with Familial Exudative Vitreoretinopathy (FEVR). Invest. Ophthalmol. Vis. Sci. 2019;60(9):6058. doi: https://doi.org/.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Familial exudative vitreoretinopathy (FEVR) is a rare, incurable genetic disorder characterized by reduced peripheral retinal vascularization during development. Half of FEVR cases are due to Norrin-FZD4 signaling mutations. We generated a fzd4-/- zebrafish model using transcription activator-like effector nucleases (TALEN) technology, with the goal of screening compounds that ameliorate this vascular defect.

Methods : The eyes of WT and fzd4-/- zebrafish were enucleated at weeks 1-12, 32, 48 post-fertilization. GFP+ fluorescent vessels were imaged using a Zeiss stereomicroscope. In addition to qualitative comparisons, the images were analyzed with ImageJ software. Optokinetic responses were elicited under white light with a spatial frequency and velocity of 0.04 cycles per degree (cpd) and 25-30rpm/sec, respectively.

Results : Zebrafish retinal vasculature is asymmetrically distributed along the dorsoventral axis, with active vascular remodeling in the ventral hemisphere of the retina throughout development. fzd4-/- mutants exhibit disorganized vascular patterning with discernable tubular fusion by week 8 of development in the ventral retina. Corresponding to these structural changes, optokinetic assays reveal that fzd4-/- mutants have impaired optokinetic response requiring increased illumination for compensation.

Conclusions : Vascular disorganization in fzd4-/- retinas appeared at week 8 in the ventral hemisphere of the retina. We have generated visually impaired zebrafish FEVR mutants that exhibit abnormal retinal vascular development. Fzd4-/- fish do not show early manifestations of disease, suggesting that techniques such as morpholinos in the study of candidate FEVR genes may miss relevant genes that contribute to FEVR pathology. These fish provide a tractable model for studying the blood vessel biology in disorders of retinal vascular development and may serve as a preclinical tool for evaluating therapeutic interventions.

This abstract was presented at the 2019 ARVO Annual Meeting, held in Vancouver, Canada, April 28 - May 2, 2019.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×